Blume Capital Management Inc. raised its holdings in shares of Oracle Corporation (NYSE:ORCL – Free Report) by 24.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 374 shares of the enterprise software provider’s stock after purchasing an additional 74 shares during the quarter. Blume Capital Management Inc.’s holdings in Oracle were worth $82,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of ORCL. Redmont Wealth Advisors LLC bought a new position in Oracle in the 1st quarter valued at about $27,000. Iron Horse Wealth Management LLC boosted its holdings in shares of Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock worth $29,000 after acquiring an additional 151 shares during the period. LGT Financial Advisors LLC acquired a new position in shares of Oracle in the second quarter valued at approximately $33,000. Legend Financial Advisors Inc. acquired a new position in shares of Oracle in the second quarter valued at approximately $34,000. Finally, HighMark Wealth Management LLC bought a new position in shares of Oracle during the second quarter worth approximately $38,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Oracle
In related news, EVP Stuart Levey sold 19,758 shares of the firm’s stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $300.00, for a total value of $5,927,400.00. Following the sale, the executive vice president directly owned 18,429 shares of the company’s stock, valued at $5,528,700. This trade represents a 51.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares in the company, valued at approximately $42,603,800.96. This represents a 20.33% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 120,769 shares of company stock worth $36,428,967. 40.90% of the stock is owned by insiders.
Oracle Trading Down 0.7%
Oracle (NYSE:ORCL – Get Free Report) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. During the same quarter in the previous year, the firm posted $1.39 earnings per share. Oracle’s quarterly revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Analysts predict that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.7%. Oracle’s dividend payout ratio is presently 46.30%.
Analysts Set New Price Targets
Several analysts recently issued reports on ORCL shares. Melius Research boosted their price target on Oracle from $270.00 to $370.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Cowen reissued a “buy” rating on shares of Oracle in a report on Friday. Baird R W upgraded shares of Oracle to a “strong-buy” rating in a research note on Wednesday, October 8th. Jefferies Financial Group raised their price target on shares of Oracle from $360.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Barclays boosted their price objective on shares of Oracle from $367.00 to $400.00 and gave the company an “overweight” rating in a report on Friday. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $323.69.
View Our Latest Report on Oracle
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles
- Five stocks we like better than Oracle
- Using the MarketBeat Stock Split Calculator
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Are Penny Stocks a Good Fit for Your Portfolio?
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What Are Treasury Bonds?
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.